Is Er Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Er Therapeutics Inc (PNGM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Er Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Er Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Er Therapeutics Inc?

Muslim investors may consider investing in Er Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Er Therapeutics Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Er Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Er Therapeutics Inc updated?

The Shariah compliance status of Er Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Er Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Er Therapeutics Inc?

You can check the latest Shariah compliance status of Er Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Er Therapeutics Inc. Stock Analysis PNGM

United States N/A Nano Cap

Pengram Corp. is an advanced gold exploration company. The company is headquartered in Bellingham, Washington and currently employs 0 full-time employees. The company went IPO on 2007-08-10. The firm has not realized any revenues from its planned operations. The firm is engaged in acquiring exploration and development of natural resource properties. The firm has not commenced business operations. The firm has interests in Clisbako claims and Eureka claims. The firm has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The firm also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.

Key Statistics of Er Therapeutics Inc (PNGM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

16.00K

P/E Ratio (TTM)

52 Week Range

$0.00$0.01

Market Cap

10.00K

Avg. Volume

1000.00

Dividend Yield

Financial Metrics & Statements of Er Therapeutics Inc (PNGM)

FAQ's for Er Therapeutics Inc (PNGM)

According to Musaffa’s Shariah screening methodology, Er Therapeutics Inc (PNGM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.